Hunan Fangsheng Pharmaceutical Co., Ltd.SSE: 603998

Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Hunan Fangsheng Pharmaceutical Co., Ltd. announced that it has passed a GMP compliance inspection for its drug production facilities, confirming adherence to regulatory standards. The inspection was conducted by the Hunan Provincial Drug Administration and covered specific production lines for key pharmaceutical products. This compliance is expected to enhance the company's production capabilities and product variety, although future sales remain subject to market and regulatory uncertainties.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Fangsheng Pharmaceutical

Later from Hunan Fangsheng Pharmaceutical

All Hunan Fangsheng Pharmaceutical news releases